| Identification | Back Directory | [Name]
L-Cysteine, L-threonyl-L-phenylalanyl-L-phenylalanyl-L-tyrosylglycylglycyl-L-seryl-L-arginylglycyl-L-lysyl-L-arginyl-L-asparaginyl-L-asparaginyl-L-phenylalanyl-L-lysyl-L-threonyl-L-α-glutamyl-L-α-glutamyl-L-tyrosyl- | [CAS]
906480-09-9 | [Synonyms]
Angiopep-2-Cys
TFFYGGSRGKRNNFKTEEYC
L-Cysteine, L-threonyl-L-phenylalanyl-L-phenylalanyl-L-tyrosylglycylglycyl-L-seryl-L-arginylglycyl-L-lysyl-L-arginyl-L-asparaginyl-L-asparaginyl-L-phenylalanyl-L-lysyl-L-threonyl-L-α-glutamyl-L-α-glutamyl-L-tyrosyl-
L-Cysteine, L-threonyl-L-phenylalanyl-L-phenylalanyl-L-tyrosylglycylglycyl-L-seryl-L-arginylglycyl-L-lysyl-L-arginyl-L-asparaginyl-L-asparaginyl-L-phenylalanyl-L-lysyl-L-threonyl-L-α-glutamyl-L-α-glutamyl-L-tyrosyl- | [Molecular Formula]
C107H154N30O32S | [MOL File]
906480-09-9.mol | [Molecular Weight]
2404.61 |
| Hazard Information | Back Directory | [Uses]
Angiopep-2-cys is a conjugate of Angiopep-2 hydrochloride (HY-P2341) and cysteine. Angiopep-2 hydrochloride is a brain peptide vector. The conjugation of anticancer agents with the Angiopep-2 peptide vector could increase their efficacy in the treatment of brain cancer[1]. | [References]
[1] Kafa H, et al. Translocation of LRP1 targeted carbon nanotubes of different diameters across the blood-brain barrier in vitro and in vivo. J Control Release. 2016 Mar 10;225:217-29. DOI:10.1016/j.jconrel.2016.01.031 |
|
|